CAR-T-ICI: COMBINATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL WITH ANTI PD-1 IMMUNE CHECKPOINT INHIBITOR AS A NOVEL TREATMENT FOR COLORECTAL CANCER: Combination of chimeric antigen receptor T-cell with anti PD-1 immune checkpoint inhibitor as a novel treatment for colorectal cancer. JIMKI. 2021;9(1):56-68. doi:10.53366/jimki.v9i1.339